Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cariprazine (RGH-188) is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
2 mg | In stock | $ 72.00 | |
5 mg | In stock | $ 110.00 | |
10 mg | In stock | $ 189.00 | |
25 mg | In stock | $ 333.00 | |
50 mg | In stock | $ 497.00 | |
100 mg | In stock | $ 693.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 110.00 |
Description | Cariprazine (RGH-188) is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM). |
Targets&IC50 | D2 receptor:0.49 nM , 5-HT1A receptor:2.6 nM, D3 receptor:0.085 nM |
Synonyms | RGH-188 |
Molecular Weight | 427.41 |
Formula | C21H32Cl2N4O |
CAS No. | 839712-12-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cariprazine 839712-12-8 GPCR/G Protein Neuroscience 5-HT Receptor Dopamine Receptor RGH188 Inhibitor Serotonin Receptor RGH 188 inhibit RGH-188 5-hydroxytryptamine Receptor inhibitor